{"id":"W4379979709","doi":"10.1002/hon.3164_421","title":"A phase II, open‐label, multicenter study of capivasertib, a potent, oral pan‐AKT inhibitor, in patients with relapsed or refractory B‐cell non‐Hodgkin lymphoma (CAPITAL)","year":2023,"lang":"en","type":"article","venue":"Hematological Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Victoria","funders":"","keywords":"Medicine; Mantle cell lymphoma; Internal medicine; Follicular lymphoma; Gastroenterology; Lymphoma; Phases of clinical research; Marginal zone B-cell lymphoma; Oncology; Clinical trial; Immunology; B cell; Marginal zone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001300271,0.001308611,0.001392079,0.000328355,0.0004109872,0.0008570991,0.0007864191,0.0008612211,0.004328784],"category_scores_gemma":[0.0005353625,0.00056442,0.0009171133,0.0003913836,0.0007838192,0.0008372679,0.0003070781,0.002448225,0.001068334],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008229523,"about_ca_system_score_gemma":0.001640513,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001051434,"about_ca_topic_score_gemma":0.002834857,"domain_scores_codex":[0.9997051,0.0001204553,0.00001748126,0.00005957698,0.00002813812,0.00006920449],"domain_scores_gemma":[0.9995505,0.00005265402,0.00007078484,0.00003843245,0.00003913489,0.0002484797],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6653131,0.1037362,0.01847967,0.001172825,0.002016901,0.0006951495,0.0005554968,0.003052294,0.07425611,0.0004087898,0.00977056,0.120543],"study_design_scores_gemma":[0.5706822,0.40136,0.01722845,0.00003394115,0.000561662,0.0004612852,0.00009591,0.001129404,0.004040061,0.0001664538,0.00421267,0.00002799511],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898496,0.001692391,0.0005119213,0.0003825432,0.00009524554,0.003104708,0.001791822,0.0001114834,0.002460427],"genre_scores_gemma":[0.9862824,0.001433201,0.00162188,0.000911073,0.0001660569,0.002997942,0.003678864,0.0000259003,0.002882837],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004328784,"threshold_uncertainty_score":0.01448125,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06263963328599681,"score_gpt":0.3822856415088418,"score_spread":0.3196460082228449,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}